Author
Listed:
- Ali Yasir Ali
(Department of Medicine, Al-Krama Teaching Hospital, Wasit, Iraq)
- Huda Khalaf Jawad
(Public Health Laboratory, Wasit Health Directorate, Wasit, Iraq)
Abstract
Cardiovascular disease (CVD) represents one of the most common causes of death on dialysis patients, which increasingly accepted as a part of excess vascular calcification that highly prevalent in patients maintained on chronic hemodialysis. This study aims to assess the prevalence of vascular calcifications among patients undergoing hemodialysis in Iraqi Center of Dialysis in Baghdad teaching hospital, and to identify the associated risk factors. A total of 94 end stage renal disease patients on regular hemodialysis from July (2024) to January 2025 were enrolled, and subjected to estimation the prevalence of vascular calcifications among those patients using Adragao score where plain X-ray of the hands and pelvis were used. Additionally, patient’s characteristics and possible risk factors were compared. The findings revealed that there were 60.42% (58/94) men and 39.58% (36/94) women were undergoing dialysis. The median age of the study population was 52 years (ranged from 44 to 60 years) and a median duration of dialysis of 24 months (ranged from 6 60 months). The majority of study patients were diabetic (82.98%) and 71.27% were diagnosed with a hypertension; while, 39.36% were having vascular calcification (Adragao score >3). Statistically, duration of dialysis (p value = 0.022), diabetes (p value = 0.015), calcium phosphate product (p value = 0.025), and serum phosphate (p value = 0.044) were associated with vascular calcifications. No significant association was found between vascular calcifications and age, gender, hypertension, corrected calcium level. In conclusion, vascular calcifications are moderately prevalent among patients undergoing hemodialysis at this center, and were found to be correlated with diabetes, duration of dialysis, calcium phosphate product, and phosphate. A larger, multicenter, prospective study need to be conducted at national level, in order to confirm the findings of this study and to identify further modifiable risk factors.
Suggested Citation
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:cxi:rjpbs0:v:3:y:2026:i:1:id:1080. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Editorial Team (email available below). General contact details of provider: https://bluemarkpublishers.com/index.php/RJPBS .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.